Bydureon BCise (exenatide) Bydureon BCise is an extended-release injectable medication for the treatment of type 2 diabetes
How Retatrutide Works Retatrutide is a next-generation medication that activates GLP-1, GIP, and glucagon receptors , meaning it works on three metabolic pathways instead of one
Many patients experience reduced appetite and fluid intake when starting GLP-1 therapy, whilst the medicine's gastrointestinal effects including nausea and occasional vomiting can further affect hydration status
Proper dose regulation often helps resolve these issues. But its hard to know for sure how long it lasts
Its crucial to discuss with your healthcare provider how much protein is safe for you, especially when managing chronic conditions alongside semaglutide treatment
Before that, the drugs had been in shortage since 2022 because of sustained heightened demand